ArticleViruses2022

Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development?

Andrew VaillantPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.